43.60
+0.80
+(1.87%)
At close: January 24 at 8:17:52 AM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALMSTEAD NEIL GREGORY Chief Operating Officer | Sale | Jan 8, 2025 | -- |
| BOULDING MARK ELLIOTT Officer | Sale | Jan 8, 2025 | 106,848 |
| GOLDEN LEE SCOTT Officer | Sale | Jan 8, 2025 | 78,651 |
| KLEIN MATTHEW B Chief Executive Officer | Sale | Jan 8, 2025 | 283,830 |
| PAUWELS ERIC Chief Executive Officer | Sale | Jan 8, 2025 | 86,805 |
| SCHMERTZLER MICHAEL Director | Stock Award(Grant) | Jan 3, 2025 | 131,266 |
| SOUTHWELL DAVID P Director | Stock Award(Grant) | Jan 3, 2025 | 18,500 |
| STEELE GLENN D JR Director | Stock Award(Grant) | Jan 3, 2025 | 18,500 |
| UTTER CHRISTINE MARIE Officer | Sale | Jan 8, 2025 | 64,321 |
| ZELDIS JEROME B. M.D., PH.D. Director | Stock Award(Grant) | Jan 3, 2025 | 18,500 |
Related Tickers
42Z.F Revolution Medicines, Inc.
38.80
0.00%
ENSCW Leisure Acquisition Corp.
0.0297
+41.43%
ANEB Anebulo Pharmaceuticals, Inc.
1.5400
-6.10%
BRNS Barinthus Biotherapeutics plc
1.0100
-10.62%
ABVC ABVC BioPharma, Inc.
0.5236
-1.86%
ELTX Elicio Therapeutics, Inc.
7.74
+7.50%
PLRX Pliant Therapeutics, Inc.
10.92
-1.97%
ACXP Acurx Pharmaceuticals, Inc.
0.8716
+5.25%
EDSA Edesa Biotech, Inc.
2.2300
+28.90%
STOK Stoke Therapeutics, Inc.
10.62
+0.19%